Researchers also report using a combination therapy may extend the life of current antiviral drugs because viruses are less likely to become resistant to such drugs when delivered in conjunction with an antibody therapy.

Influenza is one of the most serious threats to global health because of its tendency to cause pandemics. Read the original article.

The Communications and Public Affairs Office is staffed from a. to p. Monday to Friday. The University has a broadcast quality television studio to facilitate live and pre-recorded interviews with media.

Learn more about our experts. Juliet Daniel is being recognized for her groundbreaking work on triple negative breast cancer, an aggressive cancer that disproportionately affects Black and Hispanic women.

The discovery gives scientists and researchers a new target in treating allergies and could lead to new therapeutics. Skip to content. The first, penicillin, was discovered in and first used in a patient in In contrast, the first antiviral, idoxuridine, was developed as an anticancer agent in , was reported to block viruses in , and approved in to treat herpes infections of the eye.

De Clercq, a leader in early antiviral research, described his scientific journey in the Annual Review of Pharmacology and Toxicology in Plus, viruses are much trickier targets than bacteria, says Monica Gandhi, an infectious disease physician at the University of California, San Francisco.

Bacteria are whole living cells with all the metabolic pathways they need for survival, so they offer plenty of targets for attack.

That means antibiotics can interfere with cell walls, or other bacteria-specific parts and processes , to kill the pathogens without harming our own cells. And because microbes evolved antibiotics to battle each other, there is a diverse array of the compounds out in nature.

In contrast, viral pathogens live inside our own cells and depend on our proteins for most of their needs, so they offer no such easy targets. And few natural antivirals exist, so scientists need to invent them from scratch, says Kathie Seley-Radtke, a medicinal chemist at the University of Maryland, Baltimore County.

Moreover, antivirals have a limited number of possible shapes. There are ways around that problem. In the case of acyclovir, the drug that patients swallow is an inactive form, and it is mainly activated by a viral protein. There is one unfortunate similarity between antibiotics and antivirals: In both cases, pathogens can make tiny changes to their genes and proteins that leave them unharmed by the drug.

Doctors used to prescribe drugs called adamantanes to people with the flu, for example—but the influenza viruses circulating among people today are unaffected by the drugs.

The one exception to the dearth of antivirals is the flourishing pharmacopeia of meds against the human immunodeficiency virus, resulting from decades of research. Gandhi says that she can select from 30 or so medications to treat her HIV-positive patients.

More are on the way—and just as well, because HIV can quickly evolve resistance to any one drug. Drugs designed against one virus often work against others, because proteins such as the polymerases used to copy virus genomes are similar across a wide range of viruses.

But the current scourge requires more than the usual amount of cleverness from antiviral designers. The polymerase keeps adding normal nucleotides. By then, though, the coronavirus editor protein no longer works; the normal nucleotides added after remdesivir seem to get in the way, says Seley-Radtke.

Thus, the polymerase is stuck. On the plus side: In a trial of 1, people hospitalized with the virus, those who were treated with remdesivir recovered more quickly than those who received an inactive placebo.

A study highlights that coating masks with a glycoprotein called lactoferrin may help provide further protection and prevent the transmission of viruses.

Lactoferrin mimics the sticky carbohydrates present in the throat and nasal passages, which allows it to capture viral particles in airborne droplets and stop them from infecting a person. Another study notes that infusing masks with quaternary ammonium salts can also help protect against viral contamination by inactivating viruses.

Research highlights the antiviral properties of quaternary ammonium compounds against a broad spectrum of viruses. Several commercial cleaning products may kill harmful viruses.

These products can contain various active ingredients and will usually advertise their effectiveness against viruses.

Two active ingredients that household cleaning products commonly include are sodium hypochlorite and hydrogen peroxide. These two chemicals are oxidizing agents and are capable of inactivating viruses. They do so by destroying the protein coating that protects the viral genetic material.

This means that the virus can no longer reproduce. Research suggests that both of these disinfectants are effective in inactivating coronaviruses on household surfaces.

A study reported that alcohol-based hand rub solutions could inactive SARS-CoV-2, which causes COVID Several common herbs may also have antiviral properties. Their concentrated plant compounds may act to kill viruses or reduce the symptoms of the resulting diseases.

For example, oregano contains a key plant compound called carvacrol , which possesses antiviral properties that evidence suggests might be effective against SARS-CoV A study notes that compounds present in peppermint leaf extract exhibit antiviral activity against the respiratory syncytial virus.

Another study indicates that sage contains compounds that possess antiviral properties. Rosemary may also have antiviral effects. A study highlights that a compound present in rosemary called oleanolic acid displays an antiviral response against HIV and influenza.

Rosemary essential oil also shows antiviral activity against hepatitis A. Antiviral substances work to inhibit viral activity by preventing the virus from developing, replicating, and spreading. They fit under the antimicrobial umbrella but differ from antibacterial and antifungal products.

Antiviral substances include antiviral medications, which a doctor may prescribe to treat a viral infection. They also include masks and cleaning products, which may help prevent the spread of viruses, and some herbs, which have antiviral properties.

Viruses such as the novel coronavirus are highly contagious, but institutions and individuals can take many steps to limit the spread of these viruses.

Herpes antibodies occur once a person contracts the herpes virus. Read about herpes antibody tests, who should have one, what the results mean, and…. Scientists are mystified by the mechanism that 'reactivates' dormant viruses such as herpes.

Now, a new study suggests interactions with other…. Valacyclovir is a medication that can help to treat infections caused by the herpes virus. Read on for more.

Hepatology 33 , — Bartenschlager, R. Novel cell-culture systems for the hepatitis C virus. Antiviral Res. Molecular clones of hepatitis C virus: applications to animal models. ILAR J. Article PubMed Google Scholar. Pawlotsky, J. Hepatitis C virus resistance to antiviral therapy.

Hepatology 32 , — Bukh, J. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Liver Dis.

Enomoto, N. Comparison of full-length sequences of interferon-sensitive and -resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino-acid substitutions in the NS5A region. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.

This study analysed the HCV NS5A ISDR sequences in patients with chronic HCV1b infection before and after IFN therapy, and concluded that there was a substantial correlation between responses to IFN and mutations in the NS5A gene. Nakano, I. Why is the interferon sensitivity-determining region ISDR system useful in Japan?

Witherell, G. Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response.

Lohmann, V. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science , — Blight, K. Efficient initiation of HCV RNA replication in cell culture. Frese, M. Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway.

Guo, J. Effect of α-interferon on the hepatitis C virus replicon. Sumpter, R. in American Society for Virology 21st Annual Meeting W Lexington, Kentucky, Whitley, R.

com: maneuvering the internetworks of viral neuropathogenesis and evasion of the host defense. USA 97 , — Roizman, B. Ankel, H. Induction of interferon-α by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors.

Kumar-Sinha, C. Molecular cross-talk between the TRAIL and interferon signaling pathways. Preston, C. Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus.

Eidson, K. Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. Mossman, K. Herpes simplex virus ICP0 and ICP Harle, P.

Jr, Carr, D. Article PubMed CAS Google Scholar. He, B. The γ 1 USA 94 , — This study indicated a unique mechanism by which HSV γ 1 Cassady, K. The herpes simplex virus type 1 U S 11 protein interacts with protein kinase R in infected cells and requires a amino-acid sequence adjacent to a kinase substrate domain.

Leib, D. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Using recombinant viruses to infect animals that have null mutations in host-defence genes, this study showed that a virus that was attenuated by deletion of ICP Poppers, J.

Inhibition of PKR activation by the proline-rich RNA-binding domain of the herpes simplex virus type 1 US11 protein.

Esposito, J. Moss, B. Cohen, J. Smallpox vaccinations: how much protection remains? Science , Smith, G. Smallpox: anything to declare? Nature Rev. Article CAS Google Scholar. Alcami, A. Receptors for γ-interferon encoded by poxviruses: implications for the unknown origin of vaccinia virus.

Trends Microbiol. Soluble interferon-α receptors encoded by poxviruses. McFadden, G. Host-related immunomodulators encoded by poxviruses and herpesviruses. Lalani, A. Use of chemokine receptors by poxviruses.

Vaccinia, cowpox and camelpox viruses encode soluble γ-interferon receptors with novel broad species specificity. Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. Today 16 , — Virus-encoded receptors for cytokines and chemokines.

Cell Dev. Colamonici, O. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon-α transmembrane signaling. Symons, J. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity.

Cell 81 , — This study characterized the vaccinia-virus soluble type I IFN receptor encoded by the B18R gene, which has broad species specificity and might have aided vaccinia-virus replication in many host species during evolution.

Verardi, P. Vaccinia virus vectors with an inactivated γ-interferon receptor homolog gene B8R are attenuated in vivo without a concomitant reduction in immunogenicity. Sroller, V. Effect of IFN-γ receptor gene deletion on vaccinia-virus virulence.

Akkaraju, G. Vaccinia-specific kinase inhibitory factor prevents translational inhibition by double-stranded RNA in rabbit reticulocyte lysate. Watson, J. Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase.

Chang, H. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase.

USA 89 , — Beattie, E. Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3L- and E3L-mutant viruses. Vaccinia virus-encoded eIF-2α homolog abrogates the antiviral effect of interferon. Davies, M. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the α-subunit of eukaryotic initiation factor 2.

Massung, R. Analysis of the complete genome of smallpox variola major virus strain Bangladesh Shchelkunov, S. Comparison of the genetic maps of variola and vaccinia viruses. FEBS Lett. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms.

Sharp, T. The vaccinia virus E3L gene product interacts with both the regulatory and the substrate-binding regions of PKR: implications for PKR autoregulation.

Carroll, K. Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2α-specific protein kinase.

Rivas, C. Vaccinia virus E3L protein is an inhibitor of the interferon IFN -induced 2—5A synthetase enzyme. Smith, E. IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or IκB kinase but is blocked by vaccinia virus E3L protein.

Liu, Y. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity. Brandt, T. Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L , are required for pathogenesis in a mouse model.

Najarro, P. Vaccinia virus blocks γ-interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation. Cummings, C. Using DNA microarrays to study host—microbe interactions.

Fruh, K. Virogenomics: a novel approach to antiviral drug discovery. Drug Discov. Today 6 , — Manger, I. How the host 'sees' pathogens: global gene expression responses to infection. Dongre, A. Proteomics in the post-genome age. Biopolymers 60 , — Uetz, P.

A comprehensive analysis of protein—protein interactions in Saccharomyces cerevisiae. Nature , — Kellam, P. Post-genomic virology: the impact of bioinformatics, microarrays and proteomics on investigating host and pathogen interactions.

Ideker, T. A new approach to decoding life: systems biology. Genomics Hum. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network.

Simmen, K. Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. USA 98 , — Using high-density microarrays, this study identified the specific viral component that triggers the cellular IFN response as the envelope glycoprotein B gB , highlighting a pioneering paradigm for the consequences of virus—receptor interactions.

Herpes simplex virus triggers and then disarms a host antiviral response. Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling.

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. This study investigated the mechanisms of NS5A-mediated PKR regulation and the effect of ISDR mutations on this regulatory process, and proposed a model of PKR regulation by NS5A, which might have implications for therapeutic strategies against HCV.

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Noguchi, T. Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells.

Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. Girard, S. An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis.

Bigger, C. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. Toshchakov, V. Nature Immunol. This study highlighted the cross-talk between TLRs and IFN — two pivotal host anti-microbial pathways — and provided the first explanation for the mechanistic basis of the differential patterns of gene expression that are activated by different TLR agonists.

Mita, Y. Toll-like receptor 2 and 4 surface expressions on human monocytes are modulated by interferon-γ and macrophage colony-stimulating factor. Miettinen, M. IFNs activate toll-like receptor gene expression in viral infections.

Genes Immun. Aderem, A. Toll-like receptors in the induction of the innate immune response. Alexopoulou, L. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3.

This study showed that mammalian TLR3 recognizes dsRNA and TLR3 activation induces type I IFN production. It was also found that TLR3-deficient mice have reduced responses to poly inosine:cytosine. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways.

Horng, T. TIRAP: an adapter molecule in the Toll signaling pathway. O'Shea, J. Cell , S—S Aaronson, D. A road map for those who know JAK—STAT. Heim, M. The Jak—STAT pathway: cytokine signalling from the receptor to the nucleus.

Signal Transduct. Yeh, T. The Janus kinase family of protein tyrosine kinases and their role in signaling. Meraz, M. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK—STAT signaling pathway.

Cell 84 , — This study generated and characterized Stat1-deficient mice, which have a complete lack of response to IFNs and are highly sensitive to microbial and viral infection, showing that STAT1 has an obligate and dedicated role in mediating IFN-dependent biological responses.

Cox, N. Global epidemiology of influenza: past and present. Patterson, K. The geography and mortality of the influenza pandemic. Basler, C. Sequence of the pandemic influenza virus nonstructural gene NS segment and characterization of recombinant viruses bearing the NS genes.

By generating recombinant influenza viruses from cloned cDNAs, the group tested the pandemic flu NS1 gene in a mouse model. The results indicate that interaction of the NS1 protein with host-cell factors is important for viral pathogenesis.

Taubenberger, J. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the Spanish influenza virus.

Patten, P. Applications of DNA shuffling to pharmaceuticals and vaccines. Harayama, S. Artificial evolution by DNA shuffling.

Trends Biotechnol. Pekrun, K. Evolution of a human immunodeficiency virus type 1 variant with enhanced replication in pig-tailed macaque cells by DNA shuffling. Chang, C. Evolution of a cytokine using DNA family shuffling. Nature Biotechnol. This study used DNA shuffling of a family of human IFN-α genes to derive variants that have increased antiviral activities in mouse cells, and showed that diverse cytokine gene families can be used as starting material to rapidly evolve cytokines that are more active than the native form.

Weber, H. Single amino-acid changes that render human IFN-α2 biologically active on mouse cells. Download references. This work was supported by grants from the National Institutes of Health to M.

and M. We thank M. Korth for editorial assistance and N. Soong for helpful discussions. Department of Microbiology, University of Washington, Seattle, , Washington, USA. Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, , Texas, USA.

Antiviral Research, Abbott Laboratories, Abbott Park, , Illinois, USA. You can also search for this author in PubMed Google Scholar. Correspondence to Michael G. vaccinia virus. P52 RIPK. RNase L. type I IFN. A family of closely related, but slightly different, viral genomes. Viral genetics variants, derived from the original infecting virus, that are present during an infection.

A large-scale comparison of NS5A sequences isolated from IFN-resistant or IFN-sensitive HIV-infected patients. Reprints and permissions. Katze, M. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2 , — Download citation. Issue Date : 01 September Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Skip to main content Thank you for visiting nature. nature nature reviews immunology review articles article. Download PDF. Key Points Interferons IFNs — the body's first line of antiviral defence — are cytokines that are secreted by host cells in response to virus infection. Abstract The action of interferons IFNs on virus-infected cells and surrounding tissues elicits an antiviral state that is characterized by the expression and antiviral activity of IFN-stimulated genes.

Strategies to reduce the risks of mRNA drug and vaccine toxicity Article 23 January Long COVID: major findings, mechanisms and recommendations Article 13 January Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2 Article Open access 11 January Main Interferons IFNs , although best known for their antiviral properties 1 , 2 , are potent regulators of cell growth 3 and have immunomodulatory activity 4.

Figure 1: Overview of the IFN pathway and viral-counteracting strategies. Full size image. Figure 2: Interplay between the type I IFN pathway and influenza virus. Figure 3: Interplay between the type I IFN pathway and HCV. Figure 4: Interplay between the type I IFN pathway and HSV.

Figure 5: Interplay between the IFN pathways and vaccinia virus. Figure 6: The virus compendium. Box 1 Cross-talk between IFN-regulated pathways An emerging theme in the interferon IFN field is the cross-talk that occurs between the main cellular regulatory pathways.

Box 2 The IFN receptors and JAK—STAT signalling The primary players in the interferon IFN signalling pathways are the signal transducers and activators of transcription STATs and Janus kinases JAKs , see figure.

Box 3 NS1 and the great influenza pandemic of Of the influenza viruses, type A viruses cause the most illness and have caused three important worldwide outbreaks during the past century Box 4 Molecular breeding DNA shuffling, pioneered by Maxygen, Inc.

References Samuel, C. Article CAS PubMed PubMed Central Google Scholar Levy, D. Article CAS PubMed Google Scholar Grander, D. Article CAS PubMed Google Scholar Biron, C. Article CAS PubMed Google Scholar Doly, J. Article CAS PubMed Google Scholar Hwang, S. Article CAS PubMed PubMed Central Google Scholar Kamijo, R.

CAS PubMed Google Scholar Barnes, B. Article CAS PubMed Google Scholar Barnes, B. Article CAS PubMed Google Scholar Juang, Y. Article CAS PubMed Google Scholar Yeow, W. Google Scholar de Veer, M. CAS PubMed Google Scholar Der, S. Article CAS PubMed PubMed Central Google Scholar Meurs, E.

Article CAS PubMed Google Scholar Gale, M. Article CAS PubMed Google Scholar Ghosh, S. CAS PubMed Google Scholar Zhou, A. Some may feature an antiviral coating to make them more effective. A study highlights that coating masks with a glycoprotein called lactoferrin may help provide further protection and prevent the transmission of viruses.

Lactoferrin mimics the sticky carbohydrates present in the throat and nasal passages, which allows it to capture viral particles in airborne droplets and stop them from infecting a person. Another study notes that infusing masks with quaternary ammonium salts can also help protect against viral contamination by inactivating viruses.

Research highlights the antiviral properties of quaternary ammonium compounds against a broad spectrum of viruses. Several commercial cleaning products may kill harmful viruses. These products can contain various active ingredients and will usually advertise their effectiveness against viruses.

Two active ingredients that household cleaning products commonly include are sodium hypochlorite and hydrogen peroxide. These two chemicals are oxidizing agents and are capable of inactivating viruses.

They do so by destroying the protein coating that protects the viral genetic material. This means that the virus can no longer reproduce. Research suggests that both of these disinfectants are effective in inactivating coronaviruses on household surfaces. A study reported that alcohol-based hand rub solutions could inactive SARS-CoV-2, which causes COVID Several common herbs may also have antiviral properties.

Their concentrated plant compounds may act to kill viruses or reduce the symptoms of the resulting diseases. For example, oregano contains a key plant compound called carvacrol , which possesses antiviral properties that evidence suggests might be effective against SARS-CoV A study notes that compounds present in peppermint leaf extract exhibit antiviral activity against the respiratory syncytial virus.

Another study indicates that sage contains compounds that possess antiviral properties. Rosemary may also have antiviral effects.

A study highlights that a compound present in rosemary called oleanolic acid displays an antiviral response against HIV and influenza. Rosemary essential oil also shows antiviral activity against hepatitis A. Antiviral substances work to inhibit viral activity by preventing the virus from developing, replicating, and spreading.

They fit under the antimicrobial umbrella but differ from antibacterial and antifungal products. Antiviral substances include antiviral medications, which a doctor may prescribe to treat a viral infection.

They also include masks and cleaning products, which may help prevent the spread of viruses, and some herbs, which have antiviral properties. Viruses such as the novel coronavirus are highly contagious, but institutions and individuals can take many steps to limit the spread of these viruses.

Herpes antibodies occur once a person contracts the herpes virus. Read about herpes antibody tests, who should have one, what the results mean, and…. Scientists are mystified by the mechanism that 'reactivates' dormant viruses such as herpes.

Now, a new study suggests interactions with other…. Valacyclovir is a medication that can help to treat infections caused by the herpes virus.

They found that the peptoids inactivated all three enveloped viruses—Zika, Rift Valley fever, and chikungunya—by disrupting the virus membrane, but did not disrupt coxsackievirus B3, the only virus without a membrane. Moreover, chikungunya virus containing higher levels of phosphatidylserine in its membrane was more susceptible to the peptoids.

In contrast, a membrane formed exclusively with a different lipid named phosphatidylcholine was not disrupted by the peptoids, suggesting that phosphatidylserine is crucial in order for peptoids to reduce viral activity.

The researchers are continuing pre-clinical studies to evaluate the potential of these molecules in fighting viruses and to understand if they can overcome the development of resistance. Their peptoid-focused approach may hold promise for treating a wide range of viruses with membranes that can be difficult to treat, including Ebola, SARS-CoV-2, and herpes.

In addition to Kirshenbaum, Tate, and Barron, study authors include Vincent Mastrodomenico, Christina Cunha, and Bryan C. Mounce of Loyola University Chicago Medical Center; Joshua McClure of Maxwell Biosciences; and Gill Diamond of the University of Louisville School of Dentistry.

The research was supported in part by the National Science Foundation CHE and NSF GRFP and the National Institutes of Health R35GM and 1DP1 OD Kirshenbaum is the Chief Scientific Officer for Maxwell Biosciences, a biotech company that has licensed patents originating from his lab at NYU.

The company is seeking to commercialize these compounds and bring them to the clinic to advance human health. NYU Expand Breadcrumbs Click to see full trail.